Antibody fragments: Prolonging circulation half-life special issue-antibody research

Journals Menu

Follow SCIRP

	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Advances in Bioscience and Biotechnology

ISSN Print: 2156-8456
ISSN Online: 2156-8502
www.scirp.org/journal/abb
E-mail: abb@scirp.org

Google-based Impact Factor: 1.26
Citations

Journals Menu

"Antibody fragments: Prolonging circulation half-life special issue-antibody research"
written by Annabelle Patricia Herrington-Symes, Monika Farys, Hanieh Khalili, Steve Brocchini,
published by Advances in Bioscience and Biotechnology, Vol.4 No.5, 2013

has been cited by the following article(s):

Google Scholar
CrossRef

[1]	Pharmacokinetic evaluation of a single chain antibody fragment against scorpion toxins in sheep
	Hernández, L Riaño-Umbarila, B Becerril… - Toxicon, 2024

[2]	Affinity targeting to the vitreous using bispecific protein conjugates
	2023

[3]	Exploring the untapped reactivity of nitrile reagents for site-selective protein modification
	2023

[4]	Conception, synthèse et caractérisation de mimes d'anticorps monoclonaux
	2023

[5]	Bioengineering of antibody fragments: challenges and opportunities
	Bioengineering, 2023

[6]	A Non-radiometric Approach to Determine Tissue Vascular Blood Volume in Biodistribution Studies
	Moosavi, M Soto - The AAPS Journal, 2022

[7]	Development and photophysical investigations of maleimide chromophores for applications in photoactive bioconjugates
	2022

[8]	Current approaches of nanomedicines in the market and various stage of clinical translation
	Acta Pharmaceutica Sinica B, 2022

[9]	Cloning and expression of antibody fragment (Fab) I: Effect of expression construct and induction strategies on light and heavy chain gene expression
	Biochemical …, 2021

[10]	Methods to generate site-specific conjugates of antibody and protein
	Bioorganic & Medicinal Chemistry, 2021

[11]	Human Single-Chain Antibodies That Neutralize Elastolytic Activity of Pseudomonas aeruginosa LasB
	2021

[12]	Designing and Development of a Tandem Bivalent Nanobody against VEGF165
	2021

[13]	Zielgerichtete Wirkstoffe für die Krebstherapie: Aktuelle Entwicklungen und Perspektiven
	2021

[14]	Considerations for the design of antibody-based therapeutics
	2020

[15]	An Overview of the Current ADC Discovery Landscape
	2020

[16]	Targeted Engineering of Medicinal Chemistry for Cancer Therapy: Recent Advances and Perspectives
	2020

[17]	Challenges and strategies for next-generation bispecific antibody-based antitumor therapeutics
	2020

[18]	Homogenous Scavenging Resolves Low-Purification Yield/Selectivity Caused by Secondary Binding of Protein-A to Antigen-Binding Antibody Fragments
	2019

[19]	Analysis of critical quality attributes in monoclonal antibodies for upstream process development
	2019

[20]	Combining the best of two worlds: Highly flexible chimeric antigen receptor adaptor molecules (CAR-adaptors) for the recruitment of chimeric antigen receptor T cells
	2019

[21]	Overview of Antibody Drug Delivery.
	2018

[22]	Next Generation Biopharmaceuticals: Product Development
	New Bioprocessing Strategies: Development and Manufacturing of Recombinant Antibodies and Proteins, 2018

[23]	Docetaxel loaded immunonanoparticles delivery in EGFR overexpressed breast carcinoma cells
	Journal of Drug Delivery Science and Technology, 2018

[24]	Enhanced expression of soluble antibody fragments by low-temperature and overdosing with a nitrogen source
	Enzyme and Microbial Technology, 2018

[25]	Tuning the Hydrolytic Stability of Next Generation Maleimide Cross-Linkers Enables Access to Albumin-Antibody Fragment Conjugates and tri-scFvs
	Bioconjugate Chemistry, 2018

[26]	Overview of Antibody Drug Delivery
	Pharmaceutics, 2018

[27]	Sélection de fragments d'anticorps dirigés contre les microcystines pour la mise au point de tests d'immunodétection
	Thèse, 2018

[28]	Antibody fragments as potential biopharmaceuticals for cancer therapy: success and limitations
	2018

[29]	Affimer-based impedimetric biosensors: the new analytical platform for biorecognition applications
	2018

[30]	Oral Bioavailability and Lymphatic Transport of Pueraria Flavone-Loaded Self-Emulsifying Drug-Delivery Systems Containing Sodium Taurocholate in Rats.
	2018

[31]	PPI Dendronized Gold Nanoparticles for Drug Delivery Applications: Synthesis, Characterization and Biological Evaluation
	2018

[32]	Synthesis of Fc peptides and glycopeptides to be used as internal standards for absolute quantitation of glycoforms of two human IgG subclasses by MALDI-MS …
	2017

[33]	Self aggregation of IgG fragments from different perspectives
	2017

[34]	Antibody Half‐Life
	Biosimilars of Monoclonal Antibodies: A Practical Guide to Manufacturing, Preclinical, and Clinical Development, 2017

[35]	Fc Engineering for developing therapeutic bispecific antibodies and novel scaffolds
	Frontiers in immunology, 2017

[36]	Cryogel-supported stem cell factory for customized sustained release of bispecific antibodies for cancer immunotherapy
	Scientific Reports, 2017

[37]	Development of a novel nano-sized anti-VEGFA nanobody with enhanced physicochemical and pharmacokinetic properties
	South African Journal of Clinical Nutrition, 2017

[38]	Ligand-Targeted Drug Delivery
	Chemical Reviews, 2017

[39]	Microbial platform technology for recombinant antibody fragment production: A review
	Geocarto International, 2016

[40]	Approach for Half-Life Extension of Small Antibody Fragments That Does Not Affect Tissue Uptake
	Bioconjugate Chemistry, 2016

[41]	Co-stimulation Blockade Plus T-Cell Depletion in Transplant Patients: Towards a Steroid-and Calcineurin Inhibitor-Free Future?
	Drugs, 2016

[42]	Antibody Half‐Life: Engineering for Optimal Performance
	Biosimilars of Monoclonal Antibodies: A Practical Guide to Manufacturing, Preclinical, and Clinical Development, 2016

[43]	Internalisation des fragments Fab ciblant le récepteur de la transferrine au niveau des cellules endothéliales cérébrales
	2016

[44]	Evaluation of pharmacokinetics and pharmacodynamics and clinical efficacy of certolizumab pegol for Crohn's disease
	Expert opinion on drug metabolism & toxicology, 2015

[45]	Antibody Fragments and Their Purification by Protein L Affinity Chromatography
	Antibodies, 2015

[46]	Encapsidated Atom-Transfer Radical Polymerization in Qβ Virus-like Nanoparticles
	ACS nano, 2014

[1]	Pharmacokinetic evaluation of a single chain antibody fragment against scorpion toxins in sheep Toxicon, 2024 DOI:10.1016/j.toxicon.2024.107691

[2]	Pharmacokinetic evaluation of a single chain antibody fragment against scorpion toxins in sheep Toxicon, 2024 DOI:10.1016/j.toxicon.2024.107691

[3]	Antibody–Drug Conjugates—Evolution and Perspectives International Journal of Molecular Sciences, 2024 DOI:10.3390/ijms25136969

[4]	PHARMACEUTICAL AND CLINICAL CHALLENGES OF BIOLOGICAL MEDICINES: ONGOING HURDLES FROM DRUG DEVELOPMENT TO THERAPEUTIC APPLICATIONS Asian Journal of Pharmaceutical and Clinical Research, 2024 DOI:10.22159/ajpcr.2024v17i8.51398

[5]	Bioengineering of Antibody Fragments: Challenges and Opportunities Bioengineering, 2023 DOI:10.3390/bioengineering10020122

[6]	Bioengineering of Antibody Fragments: Challenges and Opportunities Bioengineering, 2023 DOI:10.3390/bioengineering10020122

[7]	Antibody‐Incorporated Nanomedicines for Cancer Therapy Advanced Materials, 2022 DOI:10.1002/adma.202109210

[8]	Current approaches of nanomedicines in the market and various stage of clinical translation Acta Pharmaceutica Sinica B, 2022 DOI:10.1016/j.apsb.2022.02.025

[9]	A Non-radiometric Approach to Determine Tissue Vascular Blood Volume in Biodistribution Studies The AAPS Journal, 2022 DOI:10.1208/s12248-022-00770-6

[10]	Cloning and expression of antibody fragment (Fab) I: Effect of expression construct and induction strategies on light and heavy chain gene expression Biochemical Engineering Journal, 2021 DOI:10.1016/j.bej.2021.108189

[11]	Cloning and expression of antibody fragment (Fab) I: Effect of expression construct and induction strategies on light and heavy chain gene expression Biochemical Engineering Journal, 2021 DOI:10.1016/j.bej.2021.108189

[12]	Methods to generate site-specific conjugates of antibody and protein Bioorganic & Medicinal Chemistry, 2021 DOI:10.1016/j.bmc.2020.115946

[13]	Human Single-Chain Antibodies That Neutralize Elastolytic Activity of Pseudomonas aeruginosa LasB Pathogens, 2021 DOI:10.3390/pathogens10060765

[14]	Zielgerichtete Wirkstoffe für die Krebstherapie: Aktuelle Entwicklungen und Perspektiven Angewandte Chemie, 2021 DOI:10.1002/ange.201914511

[15]	Targeted Engineering of Medicinal Chemistry for Cancer Therapy: Recent Advances and Perspectives Angewandte Chemie International Edition, 2021 DOI:10.1002/anie.201914511

[16]	Human Single-Chain Antibodies That Neutralize Elastolytic Activity of Pseudomonas aeruginosa LasB Pathogens, 2021 DOI:10.3390/pathogens10060765

[17]	Antibody-Drug Conjugates Methods in Molecular Biology, 2020 DOI:10.1007/978-1-4939-9929-3_1

[18]	Zielgerichtete Wirkstoffe für die Krebstherapie: Aktuelle Entwicklungen und Perspektiven Angewandte Chemie, 2020 DOI:10.1002/ange.201914511

[19]	Targeted Engineering of Medicinal Chemistry for Cancer Therapy: Recent Advances and Perspectives Angewandte Chemie International Edition, 2020 DOI:10.1002/anie.201914511

[20]	Homogenous Scavenging Resolves Low-Purification Yield/Selectivity Caused by Secondary Binding of Protein-A to Antigen-Binding Antibody Fragments Biomacromolecules, 2020 DOI:10.1021/acs.biomac.9b01516

[21]	Challenges and strategies for next-generation bispecific antibody-based antitumor therapeutics Cellular & Molecular Immunology, 2020 DOI:10.1038/s41423-020-0417-8

[22]	Homogenous Scavenging Resolves Low-Purification Yield/Selectivity Caused by Secondary Binding of Protein-A to Antigen-Binding Antibody Fragments Biomacromolecules, 2020 DOI:10.1021/acs.biomac.9b01516

[23]	Challenges and strategies for next-generation bispecific antibody-based antitumor therapeutics Cellular & Molecular Immunology, 2020 DOI:10.1038/s41423-020-0417-8

[24]	Combining the best of two worlds: Highly flexible chimeric antigen receptor adaptor molecules (CAR-adaptors) for the recruitment of chimeric antigen receptor T cells mAbs, 2019 DOI:10.1080/19420862.2019.1596511

[25]	Considerations for the Design of Antibody-Based Therapeutics Journal of Pharmaceutical Sciences, 2019 DOI:10.1016/j.xphs.2019.05.031

[26]	Antibody Fragments as Potential Biopharmaceuticals for Cancer Therapy: Success and Limitations Current Medicinal Chemistry, 2019 DOI:10.2174/0929867324666170817152554

[27]	Tuning the Hydrolytic Stability of Next Generation Maleimide Cross-Linkers Enables Access to Albumin-Antibody Fragment Conjugates and tri-scFvs Bioconjugate Chemistry, 2018 DOI:10.1021/acs.bioconjchem.7b00795

[28]	Docetaxel loaded immunonanoparticles delivery in EGFR overexpressed breast carcinoma cells Journal of Drug Delivery Science and Technology, 2018 DOI:10.1016/j.jddst.2018.03.027

[29]	Enhanced expression of soluble antibody fragments by low-temperature and overdosing with a nitrogen source Enzyme and Microbial Technology, 2018 DOI:10.1016/j.enzmictec.2018.04.002

[30]	Advances in Biochemical Engineering/Biotechnology, 2018 DOI:10.1007/10_2016_57

[31]	Overview of Antibody Drug Delivery Pharmaceutics, 2018 DOI:10.3390/pharmaceutics10030083

[32]	Tuning the Hydrolytic Stability of Next Generation Maleimide Cross-Linkers Enables Access to Albumin-Antibody Fragment Conjugates and tri-scFvs Bioconjugate Chemistry, 2018 DOI:10.1021/acs.bioconjchem.7b00795

[33]	New Bioprocessing Strategies: Development and Manufacturing of Recombinant Antibodies and Proteins Advances in Biochemical Engineering/Biotechnology, 2018 DOI:10.1007/10_2016_57

[34]	Overview of Antibody Drug Delivery Pharmaceutics, 2018 DOI:10.3390/pharmaceutics10030083

[35]	Microbial platform technology for recombinant antibody fragment production: A review Critical Reviews in Microbiology, 2017 DOI:10.3109/1040841X.2016.1150959

[36]	Fc Engineering for Developing Therapeutic Bispecific Antibodies and Novel Scaffolds Frontiers in Immunology, 2017 DOI:10.3389/fimmu.2017.00038

[37]	Development of a novel nano-sized anti-VEGFA nanobody with enhanced physicochemical and pharmacokinetic properties Artificial Cells, Nanomedicine, and Biotechnology, 2017 DOI:10.1080/21691401.2017.1369426

[38]	Ligand-Targeted Drug Delivery Chemical Reviews, 2017 DOI:10.1021/acs.chemrev.7b00013

[39]	Cryogel-supported stem cell factory for customized sustained release of bispecific antibodies for cancer immunotherapy Scientific Reports, 2017 DOI:10.1038/srep42855

[40]	Cryogel-supported stem cell factory for customized sustained release of bispecific antibodies for cancer immunotherapy Scientific Reports, 2017 DOI:10.1038/srep42855

[41]	Ligand-Targeted Drug Delivery Chemical Reviews, 2017 DOI:10.1021/acs.chemrev.7b00013

[42]	Approach for Half-Life Extension of Small Antibody Fragments That Does Not Affect Tissue Uptake Bioconjugate Chemistry, 2016 DOI:10.1021/acs.bioconjchem.6b00469

[43]	Approach for Half-Life Extension of Small Antibody Fragments That Does Not Affect Tissue Uptake Bioconjugate Chemistry, 2016 DOI:10.1021/acs.bioconjchem.6b00469

[44]	Co-stimulation Blockade Plus T-Cell Depletion in Transplant Patients: Towards a Steroid- and Calcineurin Inhibitor-Free Future? Drugs, 2016 DOI:10.1007/s40265-016-0656-2

[45]	Biosimilars of Monoclonal Antibodies 2016 DOI:10.1002/9781118940648.ch21

[46]	Evaluation of pharmacokinetics and pharmacodynamics and clinical efficacy of certolizumab pegol for Crohn’s disease Expert Opinion on Drug Metabolism & Toxicology, 2015 DOI:10.1517/17425255.2015.995166

[47]	Antibody Fragments and Their Purification by Protein L Affinity Chromatography Antibodies, 2015 DOI:10.3390/antib4030259

[48]	Encapsidated Atom-Transfer Radical Polymerization in Qβ Virus-like Nanoparticles ACS Nano, 2014 DOI:10.1021/nn502043d

[49]	Encapsidated Atom-Transfer Radical Polymerization in Qβ Virus-like Nanoparticles ACS Nano, 2014 DOI:10.1021/nn502043d

Follow SCIRP

	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Advances in Bioscience and Biotechnology

Advances in Bioscience and Biotechnology

Journals Menu

Home

About SCIRP

Service

Policies